OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Respiratory and Critical Care Medicine is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
October 1 Highlight	1934
Targeting Autotaxin and Lysophosphatidic Acid in Pulmonary Fibrosis: Admilparant’s Positive Results Show Continued Promise	470
Regulating the Regulators: Epigenetic Modulation of Regulatory T Cells in Pulmonary Hypertension	445
Reply to Jankowich: PRISm: What?s in a Name?	366
Lessons from the North: CanCOLD, Exercise, and Chronic Obstructive Pulmonary Disease	355
Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis	291
Enhancing Our Understanding of Breathing Mechanics in Nonintubated Patients with Acute Hypoxemic Respiratory Failure	244
Reply to Kasugai et al.: The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19	239
A Rare Presentation of Triple M Syndrome From Pembrolizumab	235
Severe Cytomegalovirus Pneumonitis in a Kidney Transplant Recipient: A Case Report	217
Snap, Crackle, and Pop! First Described Tracheal Diverticulum Causing Severe Pneumomediastinum in MDA5 Dermatomyositis	216
A Fatal Triad: Concurrent Pulmonary Infections With Candida, Mucorales, and Aspergillus in an Immunocompromised Patient With Underlying Vasculitis and Diabetes	210
Rituximab Induced Organizing Pneumonia; A Signal of Immunosuppression Gone Too Far	185
Sarcoidosis Unmasked Upon Discontinuation of Infliximab Therapy for Ulcerative Colitis	151
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease	148
Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions	141
No One Left Behind: Access to Prevention and Treatment for All: Message on World Lung Day from M. Patricia Rivera, M.D. President of the American Thoracic Society	137
Genetically Identifying the “Thromboembolic” in Chronic Thromboembolic Pulmonary Hypertension	135
Significant Airway Obstruction by Carbonaceous Fibrin Casts in a Child with Smoke Inhalation Injury	120
Extending the Benefits of Pulmonary Rehabilitation to New Groups: Reply to Anidi et al.	117
Heat Wave Risks for People with Lung Disease	116
Microplastics in Human Bronchoalveolar Lavage Fluid	116
Proximal Hypoglossal Nerve Stimulation Improves Sleep-disordered Breathing in Moderate to Severe Obstructive Sleep Apnea: The Osprey Randomized, Controlled Trial	115
Reduction in the Use of Rescue Medication for Asthma Symptom Relief With Rilzabrutinib: Results From a Phase 2 Study	113
Cystic Fibrosis: Huge Gains, but Still a Work in Progress	111

In Case of Invasive Nodule, Break Ground Glass	110
Constructing Modern Pulmonary Rehabilitation: Another Brick from the Wall	107
Electrical Impedance Tomography to Evaluate Sigh Effects in Unilateral Lung Injury	105
Mycobacterium tuberculosis: A Pathogen That Can Hold Its Breath a Long Time	103
Mediastinal Lymph Node Silicotic Nodules and Occupational Exposure to Respirable Crystalline Silica: A Controlled Study in Patients with Lung Cancer	100
CD4⁺T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent	99
Impaired Lung Function in Extremely Preterm–Born Adults in Their Fourth Decade of Life	99
Pulmonary Embolus and Hemoptysis Revealing Rare Intralobar Sequestration	97
Risks and Benefits of Ultra–Lung-Protective Invasive Mechanical Ventilation Strategies with a Focus on Extracorporeal Support	96
Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)	95
Phase III FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis	95
Air Pollution and Bronchitis: Childhood Exposure, Lifelong Consequences	95
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation	95
Silent Slowdown: Unmasking Myxedema Coma in an Elderly Patient	95
Clinical Guidelines: Asking the Right Questions to Guide Fungal Infection Management	94
Reply to Hsiao and Chen: Refining the Concept of Disease Stability in Chronic Obstructive Pulmonary Disease: Bridging Complexity and Clinical Practice	92
E-cigarette Modulation of Leukocyte Activation in Lung and Airways and T Cell Numbers in Lung-draining Lymph Nodes in the Setting of Influenza Infection	91
An Epigenetic Association Between Heightened Airway Hyperreactivity and Maternal Exposure to Particulate Air Pollution	90
Long-term Survival of Lung Transplant Recipients With Early Post-operative Atrial Fibrillation Treated With Amiodarone	89
Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?	84
Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults	84
Interventions Relieving Dyspnea in Intubated Patients Show Responsiveness of the Mechanical Ventilation–Respiratory Distress Observation Scale	81
Emergency Intubation: A High-Stakes Procedure with Critical Gaps in Understanding Team Impact	79
Extracorporeal Membrane Oxygenation Transport for Severe COVID-19: Why We Can and Should!	78
Robotic versus Electromagnetic Bronchoscopy for Peripheral Pulmonary Lesions: A Randomized Trial (RELIANT)	78
Be the Change: Advancing Lung Health and Closing the Global Healthcare Gap	76
Does Autoimmune Response Against Surfactant Protein Cause Interstitial Lung Disease?	75
Why Home Noninvasive Ventilation Should Begin in the Hospital, Not at Home	75
Diaphragm Dysfunction as a Contributor to Breathlessness after COVID-19 Infection	74
Endobronchial Clear-Cell Sugar Tumor	74
Alveolar Collapse Is a Threat in Injured Lungs, but What About the Airway Opening Pressure?	74
Good’s Syndrome: Thymoma with Acquired Immunodeficiency	74
Use FEV₁/FVC Z-Score Staging to Minimize Sex and Age Bias in Staging Chronic Obstructive Pulmonary Disease	73
Nasal High Flow to Modulate Dyspnea in Orally Intubated Weanable Patients	73
Race-based Reference Equation for Lung Function Testing in African Americans	73
Reply to Wendel-Garcia et al.: Low-Dose Anticoagulation to Prevent Intracranial Hemorrhage in COVID-19 Patients under Extracorporeal Membrane Oxygenation Support	73
Chronic Obstructive Pulmonary Disease Detection: Hurdles and Struggles	69
Organizing Pneumonia Secondary to COVID-19 Pneumonia in an Immunocompromised Patient	69
Radiographic Riddle: Atypical Presentation of Acute Eosinophilic Pneumonia	69
CPAP/BiPAP Administration and Cardiac Arrest Events in Hospitalized OSA/OHS Patients	68
Association of the Q223R Leptin Receptor Polymorphism With Bacterial Pneumonia in the Michigan Genomics Initiative	67
Medical Necessity: When Patients and Providers Disagree	67